A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort

Home / Key Publications / Digital Algorithms / A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort

You May Also Like

Cost Utility of Novel Biomarker Based Strategies for Hepatocellular Carcinoma HCC Surveillance in Thailand featured image

Health Economics

27 June 2024

Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in Thailand

Expert Opinions

13 May 2024

No woman left behind: Increasing access to testing for cervical cancer elimination

Expert Opinions

13 May 2024

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.